CClinicalTrials.gg
CompletedNCT05421910Updated Sep 18, 2023

Clinical Feasibility of ROBERT-SAS in Severely Impaired Stroke Patients

An interventional study of robotic training combined with electrical stimulation in Stroke, sponsored by Roessingh Research and Development. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-18.

Sponsored by Roessingh Research and Development · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Robotic training can be used to provide intensive training during the (early phases of) rehabilitation of a stroke. ROBERT®-SAS training is designed to create an active and intensive training tool for the rehabilitation of the lower extremity of stroke patients. Currently this has only be tested in a lab-based setting, which showed that is was feasible and could be executed while still being comfortable for the patient. The next step will be implementing the device in a clinical setting. Therefore, aims the current study to assess the feasibility of ROBERT®-SAS training in clinical setting, in acute stroke patients.

Read the detailed description

Rationale: Stroke is one of the leading causes of disability of adults in the European Union. Around 80% of stroke survivors experience deficits in motor control, resulting in problems with keeping balance and walking, for instance. The extent and amount of deficits differ per individual. Interventions to train the lower extremity almost always consist of walking exercises. However, patients in the acute phase or with severely affected lower extremity function are often unable to walk or to walk independently. Therefore, the combination of a robot (ROBERT®) and functional electrical stimulation (ES) is being developed to provide a training tool for early rehabilitation. In the current study a combination of robot and ES will be evaluated in clinical setting.

Objective: The primary objective of the current study is to assess the feasibility of ROBERT®-SAS training in clinical setting, in acute stroke patients, including patient and therapist perspectives.

Study design: The current study is an observational study.

Study population: In the current study ten (sub) acute stroke patient will be included, with severely affected lower extremity. Five of these ten will be included as soon as possible after arrival at the rehabilitation centre. Another five will be included 3-5 weeks after arrival/start of the rehabilitation.

Main study parameters/endpoints: The main outcome parameter is the SUS score from both the patients and the therapists.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The current study consists of several measurement sessions in Roessingh Rehabilitation Centre, during the normal rehabilitation time. The robot, ROBERT® is CE-certified. However, the combination ROBERT®-SAS, combining both ES and robot support, is not, although previous tests have shown this approach is possible and tolerable by healthy persons and stroke patients. The risks are regarded as minimal because it is without invasive procedures, with room for rest in between trial sets as required by the participant, and application of individual stimulation profiles to not exceed tolerance levels or inflict pain during electrostimulation.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Robotic
  • Electrical stimulation
  • Lower extremity
  • Stroke
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 9 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Roessingh Research and Development is the lead sponsor of 9 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Sub(acute) stroke (\< 6 months post-stroke)
  • Above 18 years
  • Able to provide informed consent
  • An ischemic or haemorrhagic stroke
  • Hemiparetic lower extremity

Exclusion criteria

Exclusion Criteria:

  • Premorbid disability of lower extremity
  • Severe cognitive impairment, unable to follow simple instructions and unable to understand Dutch.
  • Skin lesions at the hemiparetic leg
  • Progressive neurological diseases (i.e. Parkinson, dementia, etc.)
  • Contraindication for mobilization like unhealed lower limb fracture
  • Use of pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Early training group

    The early group will receive robotic training combined with electrical stimulation as soon as possible after submission to the rehab center. With a frequency of three times a week for 3-5 weeks, dependent on the capabilities of the patients.

    Device: robotic training combined with electrical stimulation

  • Active comparator
    Late training group

    The late training group will receive robotic training combined with electrical stimulation 3-5 weeks after submission to the rehab center. With a frequency of three times a week for 3-5 weeks, dependent on the capabilities of the patients.

    Device: robotic training combined with electrical stimulation

Interventions

  • Devicerobotic training combined with electrical stimulation

    Active training of movements in supine position. Movements such as knee extension and ankle dorsal flexion.

06

What researchers measure

Primary outcomes

  1. System Usability Scale (SUS) score

    The System Usability Scale of patients and therapists. 10 questions with a 5-point response scale. The total score can range from 0 - 100, in which a higher score indicates a better usability

    Time frame: 15 minutes

Secondary outcomes

  1. Electromyography (EMG)

    Surface EMG of the muscle that will be stimulated with electrical stimulation, expressed in volt.

    Time frame: 30 minutes

  2. Force

    Resulting force measured with the robot, expressed in kg

    Time frame: 30 minutes

  3. Frequency

    As a settings of the stimulation expressed in Hertz

    Time frame: 30 minutes

  4. Assist-As-Needed (AAN) stages

    The trajectory completion rate for the different stages of AAN. (different types of assistance). There are three different types, no assistance, electrical stimulation assistance and an combination of electrical stimulation and robot support.

    Time frame: 30 minutes

  5. Fugl-Meyer Assessment (FMA)

    Lower extremity module, to assess leg function. Scores can range between 0 and 28, in which a higher score indicates a higher leg function.

    Time frame: 10 minutes

  6. Motricity Index (MI)

    Lower extremity part, to assess the leg function. Scored for Ankle, knee and hip separately between 0 - 33 in which zero is know movement and 33 is normal movement. Total score can range between 0 - 99. (summation of the three joints)

    Time frame: 10 minutes

  7. Functional Ambulation Categories (FAC)

    To assess the walking capabilities, score between 0 and 5, in which 5 indicates a better walking capability.

    Time frame: 5 minutes

  8. Type of movement

    Type of movement that will be trained during the measurements. Can be knee extension or ankle dorsal flexion with electrical stimulation.

    Time frame: 30 minutes

  9. Questionnaire Experience

    Questions about their experience with ROBERT for all stakeholders. Open questions which will not have a score, but will be interpreted on question level.

    Time frame: 15 minutes

  10. Pulse width of the electrical stimulation

    As a settings of the stimulation expressed in milliseconds

    Time frame: 30 minutes

  11. Amplitude of the electrical stimulation

    As a settings of the stimulation expressed in milliampere

    Time frame: 30 Minutes

  12. Amount of repetitions

    The amount of repetitions during one set of a specific movement.

    Time frame: 30 minutes

  13. Resistance level

    The amount of resistance during the training, can be changed during a set if necessary. The resistance can differ between 0-10, in which 10 is the heaviest.

    Time frame: 30 minutes

Other outcomes

  1. Gender

    gender will be noted as subject characteristic

    Time frame: 1 minutes

  2. Age

    Age will be noted as subject characteristic in years

    Time frame: 1 minutes

  3. Time since stroke

    time science stroke will be noted as subject characteristic in months

    Time frame: 1 minutes

  4. Weight

    Weight will be noted as subject characteristic and used for BMI calculation, noted in kg

    Time frame: 1 minutes

  5. Height

    Height will be noted as subject characteristic and used for BMI calculation, noted in meters

    Time frame: 1 minutes

  6. Affected side

    The affected side will be used as subject characteristic

    Time frame: 1 minutes

07

Study locations

1 site
  • Roessingh Research and Development
    Enschede, Overijssel 7522AH, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05421910
Lead sponsor
Roessingh Research and Development
Collaborators
Aalborg University, Lifescience-Robotics
Responsible party
Sponsor
First posted
Jun 16, 2022
Start date
Jul 11, 2022
Primary completion
Aug 24, 2023
Completion
Aug 24, 2023
Last update
Sep 18, 2023

Study contacts

Gerdienke Prange, PhD
principal investigator · Roessingh Research and Development

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion